RINDI, Guido
 Distribuzione geografica
Continente #
NA - Nord America 3.534
AS - Asia 2.673
EU - Europa 2.194
SA - Sud America 402
AF - Africa 137
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 8.949
Nazione #
US - Stati Uniti d'America 3.418
SG - Singapore 1.162
CN - Cina 856
UA - Ucraina 464
IE - Irlanda 447
SE - Svezia 354
FI - Finlandia 319
BR - Brasile 318
DE - Germania 245
HK - Hong Kong 243
VN - Vietnam 196
ZA - Sudafrica 111
NL - Olanda 104
CA - Canada 85
GB - Regno Unito 84
IT - Italia 57
TR - Turchia 57
IN - India 50
AR - Argentina 40
RU - Federazione Russa 28
BD - Bangladesh 24
BE - Belgio 17
MX - Messico 17
FR - Francia 15
IQ - Iraq 14
CZ - Repubblica Ceca 13
ES - Italia 11
VE - Venezuela 11
EC - Ecuador 10
CO - Colombia 8
JP - Giappone 8
MA - Marocco 8
PL - Polonia 8
EU - Europa 7
ID - Indonesia 7
KE - Kenya 7
JO - Giordania 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CL - Cile 5
IL - Israele 5
PE - Perù 5
PK - Pakistan 5
BG - Bulgaria 4
KZ - Kazakistan 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
EG - Egitto 3
JM - Giamaica 3
KG - Kirghizistan 3
PT - Portogallo 3
PY - Paraguay 3
SA - Arabia Saudita 3
AL - Albania 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
IR - Iran 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
SV - El Salvador 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.949
Città #
Singapore 500
Chandler 464
Jacksonville 451
Dublin 446
Santa Clara 338
Ashburn 313
Beijing 259
Dearborn 244
Hong Kong 243
Boardman 136
Nanjing 121
Johannesburg 106
Princeton 100
San Mateo 97
Dallas 80
Ann Arbor 78
Ho Chi Minh City 76
Los Angeles 76
Toronto 68
Wilmington 62
Izmir 50
Helsinki 48
Hanoi 44
Shanghai 33
Nanchang 32
Munich 31
Hebei 30
Pune 30
Buffalo 28
Kunming 28
New York 28
Shenyang 28
Jinan 26
São Paulo 22
Hefei 20
Woodbridge 20
Tianjin 19
Brussels 17
Changsha 15
Moscow 15
Guangzhou 14
Norwalk 12
Haiphong 11
Hangzhou 11
Jiaxing 11
London 11
Columbus 10
Zhengzhou 10
Belo Horizonte 9
Chennai 9
Rio de Janeiro 9
Stockholm 9
Turku 9
Borås 8
Des Moines 8
Parma 8
Auburn Hills 7
Bremen 7
Brno 7
Can Tho 7
Fremont 7
Nairobi 7
Ottawa 7
Redondo Beach 7
Amman 6
Campinas 6
Taiyuan 6
Tashkent 6
Warsaw 6
Baku 5
Brooklyn 5
Da Nang 5
Haikou 5
Hải Dương 5
Prague 5
Rockville 5
Seattle 5
Brasília 4
Buenos Aires 4
Caracas 4
Casablanca 4
Chicago 4
Curitiba 4
Franca 4
Fuzhou 4
Grafing 4
Guarulhos 4
Joinville 4
Juiz de Fora 4
Marseille 4
Mexico City 4
Ningbo 4
Nova Iguaçu 4
Nuremberg 4
Paris 4
Quảng Ngãi 4
San Francisco 4
Sofia 4
Thái Nguyên 4
Tokyo 4
Totale 5.199
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 160
Endocrine tumors of the gastrointestinal system 138
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 138
A high resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications 138
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 137
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 133
A randomised, double-blind, trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over five years 124
Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor deficient mice. 123
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 121
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 121
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 117
Consensus guidelines for the management of patients with digestive neuroendocrine tumors: the second event and some final considerations 116
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non small cell lung cancer(NSCLC) and fine needle aspirates from distant metastatic sites. 116
CONSENSUS GUIDELINES ON THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS: WHY SUCH GUIDELINES AND HOW WE WENT ABOUT IT. 115
Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors 112
Consensus guidelines for the management of patients with digestive neuroendocrine tumors -4- well-differentiated pancreatic tumor/carcinoma: insulinoma. 111
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 111
Criteria for malignancy in gastrointestinal endocrine tumors 110
Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. 109
GHRELIN PROTECTS AGAINST ETHANOL-INDUCED GASTRIC ULCERS IN RATS: STUDIES ON THE MECHANISMS OF ACTION 107
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 107
Unusual case of giant typical carcinoid tumor 105
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS -2- WELL-DIFFERENTIATED DUODENAL TUMOR/CARCINOMA (EXCLUDING GASTRINOMAS). 104
Characterisation of gastric ghrelin cells in man and other mammals – Studies in adult and foetal tissues 102
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer 102
Etiology, molecular pathogenesis and genetics 101
Classification of the neuroendocrine phenotype in cancer 101
Three different synchronous unilateral lung cancers: a case report 101
Autoimmune gastritis 100
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE ENDOCRINE TUMORS -1- WELL-DIFFERENTIATED GASTRIC TUMORS/CARCINOMAS. 99
Genetic alterations in poorly differentiated endocrine colon carcinomas developing in tubulo-villous adenomas: a report of two cases 98
Optimisation of isolation of richly pure and homogenous primary human colonic smooth muscle cells 97
Classification of neuroendocrine tumours. 97
Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. 97
Anatomia patologica e tumori rari 95
Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract 95
Central Ghrelin gastroprotection involves nitric oxide/prostaglandins cross-talk. 91
Primary mixed adenocarcinoma and small cell carcinoma of the appendix. A clinicopathologic, immunohistochemical and molecular study of a hitherto unreported tumor 90
Ghrelin expression and actions. A novel peptide for an old cell type of the diffuse endocrine system 89
Ghrelin in gastroenteric pathophysiology 89
Prognostic value of Goseki histological classification of adenocarcinoma of the cardia 89
Linee guida e criteri diagnostici minimi per la diagnosi istologica dei tumori endocrini del tratto gastroenteropancreatico 88
Endoscopic surgical treatment of pleomorphic adenoma of the inferior nasal turbinate. 85
Highlights on biology of endocrine tumours of the gut and pancreas 85
GI Tract, General Pathology of Endocrine Growths 84
Sudden onset of colitis after ablation of secretin-expressing lymphocytes in transgenic mice 84
Solitary microcarcinoid of the rectal stump in ulcerative colitis. Case report 84
Il pancreas endocrino. 84
Unusual prostatic carcinoma with endocrine basophilic FSH-immunoreactive cells 83
Mismatch repair system (MMR) status correlates with response and survival in non small cell lung cancer (NSCLC) patients. 83
Peptide YY expression is an early event in intestinal endocrine cell differentiation: evidence from normal and transgenic mice. 83
Prognostic relevance of a novel TNM-classification system for gastroenteropancreatic neuroendocrine tumors of foregut origin 83
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system 82
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinico-pathologic study. 81
The phenotype of gut endocrine tumors 81
Gastrinomas 80
Gastroenteropancreatic neuroendocrine tumours. 80
Development of neuroendocrine tumors in the gastro-intestinal tract of transgenic mice: heterogeneity of hormone expression. 80
Transient developmental expression of secretin in serotoninergic neurons of mouse brain 79
Epidemiology of carcinoid neoplasm in Vaud, Switzerland, 1974-1997 79
Introduction to a revised clinicopathological classification of the neuroendocrine tumors of the gastroenteropancreatic tract 78
PYY-Tag transgenic mice displaying abnormal (H(+)-K(+)ATPase activity and gastric mucosal barrier impairment 78
Targeted ablation of secretin cells reveals a close developmental relationship with CCK and L cells 78
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa 78
Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma 78
Molecular aspects of the endocrine tumors of the pancreas and the gastrointestinal tract 77
Insulinoma 77
A Refractory pleural small cell carcinoma in never smoker. A case report. 77
The ontogeny and tissue specific regulation of ghrelin mRNA expression in the rat strongly indicate that ghrelin is primarily involved in the control of extraendocrine functions 76
Prognostic factors in gastrointestinal endocrine tumors 76
The endocrine pancreas 75
Gastric endocrine cells: types function and growth 75
Pathobiology and classification of digestive endocrine tumors 74
Neuroendocrine tumors: history and histopathology 74
Effects of long-term esomeprazole treatment on the gastric mucosa 74
Évaluation de la malignité dans les tumeurs endocrines digestives: recommandations pratiques. 74
Origin and genetic background of insulinoma 73
Is TCRg clonality assay useful to detect early celiac disease? 73
Gastric neuroendocrine tumors - carcinoid and poorly differentiated carcinoma 73
Histogenesis, diagnosis and molecular basis of the endocrine tumors of the digestive tract and pancreas 73
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. 73
The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumors: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. 73
TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. 72
Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types. 71
Dilated intercellular spaces as marker of reflux disease: histology, semiquantitative score and morphometry at light microscopy 70
Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database 70
Vesicular monoamine transporter 2 as a marker of gastric ECL cell tumors 69
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours. 69
Endocrine tumours of the gut and pancreas tumor biology and classification 68
Ghrelin expression in gut endocrine tumours 68
Effect of CCK-B gastrin receptor blockade on chemically-induced colon carcinogenesis in mice: follow-up at 52 weeks 68
Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active ß-catenin. 67
The normal endocrine cell of the gut. Changing concepts and new evidences 66
Endocrine and extraendocrine activity of ghrelin and the GHS: basic research 66
Pathology and biology of gastric neuroendocrine tumors in man 65
Morphological, molecular, and prognostic aspects of gastric endocrine tumors 60
Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. 58
Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells 57
Pancreatic endocrine tumors 54
Dilated intercellular spaces: a major morphological feature of esophagitis. 54
Totale 8.903
Categoria #
all - tutte 30.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.485


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021346 0 0 0 0 0 6 97 0 117 10 110 6
2021/2022455 4 1 0 28 17 6 67 97 18 36 63 118
2022/20231.595 197 156 62 129 155 173 15 101 551 10 38 8
2023/2024458 20 71 9 15 41 141 12 16 6 14 38 75
2024/20251.934 19 115 143 60 262 319 32 51 249 217 122 345
2025/20261.873 266 364 329 323 575 16 0 0 0 0 0 0
Totale 8.961